NCT04485988

Brief Summary

To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

July 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 24, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

June 24, 2021

Status Verified

June 1, 2021

Enrollment Period

5.4 years

First QC Date

July 22, 2020

Last Update Submit

June 22, 2021

Conditions

AMI

Outcome Measures

Primary Outcomes (1)

  • Death

    all-cause mortality

    The median time of 3 years

Study Arms (2)

No-beta blocker

beta blocker

Drug: Beta blocker

Interventions

Beta blockerDRUG

Duration of medication

beta blocker

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The enrolled patients were from the First Affiliated Hospital of Chongqing Medical University, and the patient information was obtained from the medical record system

You may qualify if:

  • Patients with acute myocardial infarction

You may not qualify if:

  • Previous history of heart failure admission Killip class \> I class cancer pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400016, China

RECRUITING

MeSH Terms

Interventions

Adrenergic beta-Antagonists

Intervention Hierarchy (Ancestors)

Adrenergic AntagonistsAdrenergic AgentsNeurotransmitter AgentsMolecular Mechanisms of Pharmacological ActionPharmacologic ActionsChemical Actions and UsesPhysiological Effects of Drugs

Study Officials

  • dongying zhang, doctor

    First Affiliated Hospital of Chongqing Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

dongying zhang, doctor

CONTACT

86.27.8901.1596zhangdongying@cqmu.edu.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 22, 2020

First Posted

July 24, 2020

Study Start

July 1, 2015

Primary Completion

December 1, 2020

Study Completion

July 1, 2021

Last Updated

June 24, 2021

Record last verified: 2021-06

Locations

CN(1)